Gary T Steele Net Worth

The estimated Net Worth of Gary T Steele is at least $5.81 Million dollars as of 23 May 2018. Gary Steele owns over 24,286 units of Lifecore Biomedical Inc stock worth over $984,642 and over the last 21 years Gary sold LNDC stock worth over $4,822,602.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Gary Steele LNDC stock SEC Form 4 insiders trading

Gary has made over 65 trades of the Lifecore Biomedical Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Gary exercised 24,286 units of LNDC stock worth $331,504 on 23 May 2018.

The largest trade Gary's ever made was exercising 554,709 units of Lifecore Biomedical Inc stock on 22 March 2007 worth over $4,642,914. On average, Gary trades about 28,660 units every 59 days since 2003. As of 23 May 2018 Gary still owns at least 112,402 units of Lifecore Biomedical Inc stock.

You can see the complete history of Gary Steele stock trades at the bottom of the page.

What's Gary Steele's mailing address?

Gary's mailing address filed with the SEC is 3603 HAVEN AVENUE, C/O LANDEC CORPORATION, MENLO PARK, CA, 94025.

Insiders trading at Lifecore Biomedical Inc

Over the last 21 years, insiders at Lifecore Biomedical Inc have traded over $49,493,033 worth of Lifecore Biomedical Inc stock and bought 1,245,307 units worth $12,385,872 . The most active insiders traders include Nicholas Tompkins, Partners Small Cap Value Lp..., and Gary T Steele. On average, Lifecore Biomedical Inc executives and independent directors trade stock every 17 days with the average trade being worth of $253,944. The most recent stock trade was executed by Partners Small Cap Value Lp... on 24 October 2022, trading 250,000 units of LNDC stock currently worth $2,022,500.

What does Lifecore Biomedical Inc do?

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.

Complete history of Gary Steele stock trades at Lifecore Biomedical Inc

Lifecore Biomedical Inc executives and stock owners

Lifecore Biomedical Inc executives and other stock owners filed with the SEC include:

• Dr. Albert D. Bolles Ph.D.,
  CEO, Pres & Director
• Albert Bolles,
  President, Chief Executive Officer, Director
• James Hall,
  Vice President, President of Lifecore
• James G. Hall,
  VP & Pres of Lifecore
• Timothy Burgess,
  Senior Vice President of Supply Chain for Curation Foods
• Brian McLaughlin,
  Chief Financial Officer, Secretary
• John D. Morberg,
  CFO & Sec.
• Timothy P. Burgess,
  Sr. VP of Supply Chain - Curation Foods
• Dawn Kimball,
  Chief Human Resource Officer, Senior Vice President
• Andrew Powell,
  Independent Director
• Tonia Pankopf,
  Independent Director
• Deborah Carosella,
  Independent Director
• Catherine Sohn,
  Independent Director
• Nelson Obus,
  Independent Director
• Katrina Houde,
  Independent Director
• Craig Barbarosh,
  Independent Chairman of the Board
• Charles Macaluso,
  Independent Director
• Patrick Walsh,
  Director
• Joshua Schechter,
  Director
• Jeffrey Edwards,
  Director
• Parker K. Javid,
  VP
• Aaron Perlitsh,
  Director of Internal Audit & Chief Compliance Officer
• Steven D Goldby,
  Director
• Ronald Lane Midyett,
  Executive Vice President
• Nicholas Tompkins,
  CEO & President, Apio Inc.
• Robert Tobin,
  Director
• Steven P Bitler,
  Vice President, Technology
• Larry D Hiebert,
  Executive Vice President
• Molly Hemmeter,
  VP Business Development
• Gary T Steele,
  President & CEO
• Gregory S Skinner,
  Chief Financial Officer
• John D Morberg,
  Chief Financial Officer
• Parker K Javid,
  Vice President
• Dennis J Allingham,
  Executive Vice President
• Richard Dulude,
  Director
• Kenneth E Jones,
  Director
• Richard Dean Hollis,
  Director
• Duke K Bristow,
  Director
• Kirby L Cramer,
  Director
• Stephen E Halprin,
  Director
• David D Taft,
  Director
• Lawrence Greene,
  V.P. Manufacturing
• Frederick Frank,
  Director
• Partners Small Cap Value Lp...,
  
• Damian A. Hajduk,
  Chief Scientific Officer
• Thomas F Crowley,
  CEO, LandecAg
• Richard S Schneider,
  Director
• Fred Frank,
  Director
• Raymond H Diradoorian,
  Director